{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:51:27Z","timestamp":1781643087726,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400797"],"award-info":[{"award-number":["82400797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017287","name":"Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China","doi-asserted-by":"publisher","award":["20234Y0210"],"award-info":[{"award-number":["20234Y0210"]}],"id":[{"id":"10.13039\/501100017287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Monogenic lupus is a rare but severe form of systemic lupus erythematosus (SLE) that typically manifests during childhood. Mutations in\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      cause lysinuric protein intolerance (LPI), and this gene has been implicated in monogenic lupus. This study aimed to investigate the clinical features, treatment strategies, and outcomes of pediatric patients with monogenic lupus caused by\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      mutations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective single-center study of pediatric patients with SLE who fulfilled the 2012 SLICC and\/or 2019 EULAR\/ACR classification criteria and underwent next-generation sequencing because of early onset or atypical clinical features. Patients carrying biallelic pathogenic or likely pathogenic variants in\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      together with biochemical evidence of LPI were classified as having\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      -associated monogenic lupus. Their clinical and immunological characteristics, treatment strategies, and outcomes were compared with those of SLE patients without identifiable monogenic variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among pediatric SLE patients who underwent next-generation sequencing for suspected monogenic etiology, six were identified with biallelic\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      variants and biochemical evidence of lysinuric protein intolerance, accounting for 31.6% of all monogenic lupus cases in this cohort. The mean age at SLE diagnosis in the\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      -associated monogenic lupus group was 6.6 years, and patients were followed for an average of 5.5 years. In the overall LPI cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912), the median age of symptom onset was 1 year and the mean age at LPI diagnosis was 7.7 years. The recurrent splice-site mutation c.625\u2009+\u20091G\u2009&gt;\u2009A was the most frequent variant, detected in 14 of 24 alleles. Compared with gene-negative SLE patients, those with\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      -associated monogenic lupus more frequently exhibited protein intolerance, osteopenia, short stature, and hyperferritinemia (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Treatment consisted of combined immunosuppressive and metabolic therapies, and at the last follow-up 83.3% (5\/6) of patients had achieved and maintained a Lupus Low Disease Activity State (LLDAS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In Chinese patients with lysinuric protein intolerance, this study suggests an association with an increased susceptibility to developing SLE. Given the small LPI-SLE subgroup, these findings require validation in larger cohorts. Within this cohort, the splice-site mutation c.625\u2009+\u20091G\u2009&gt;\u2009A was the most frequently observed\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      variant. Furthermore, in children diagnosed with SLE, the presentation of a metabolic triad\u2014protein intolerance, short stature, and osteopenia\u2014should raise suspicion for\n                      <jats:italic>SLC7A7<\/jats:italic>\n                      -associated monogenic lupus and prompt genetic and metabolic evaluation, which could facilitate early diagnosis and timely intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04258-w","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:23:15Z","timestamp":1773368595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monogenic lupus with SLC7A7 mutations: a retrospective study from a Chinese center"],"prefix":"10.1186","volume":"21","author":[{"given":"Yifan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinv","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"4258_CR1","doi-asserted-by":"publisher","unstructured":"Arnaud L, Fagot JP, Mathian A, Paita M, Fagot-Campagna A, Amoura Z. Prevalence and incidence of systemic lupus erythematosus in france: a 2010 nation-wide population-based study. Autoimmun Rev. 2014;13(11):1082\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.034.","DOI":"10.1016\/j.autrev.2014.08.034"},{"issue":"9","key":"4258_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","volume":"6","author":"S Kamphuis","year":"2010","unstructured":"Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6(9):538\u201346. https:\/\/doi.org\/10.1038\/nrrheum.2010.121.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"4258_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5152\/TurkArchPediatr.2024.24097","volume":"59","author":"P Avar-Ayd\u0131n","year":"2024","unstructured":"Avar-Ayd\u0131n P, Brunner HI. Revisiting Childhood-Onset systemic lupus erythematosus. Turk Arch Pediatr. 2024;59(4):336\u201344. https:\/\/doi.org\/10.5152\/TurkArchPediatr.2024.24097.","journal-title":"Turk Arch Pediatr"},{"issue":"Si2","key":"4258_CR4","doi-asserted-by":"publisher","first-page":"Si210","DOI":"10.1093\/rheumatology\/keac275","volume":"62","author":"A Charras","year":"2023","unstructured":"Charras A, Haldenby S, Smith EMD, Egbivwie N, Olohan L, Kenny JG, et al. Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. Rheumatology (Oxford). 2023;62(Si2):Si210\u201325. https:\/\/doi.org\/10.1093\/rheumatology\/keac275.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4258_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00439-018-01966-7","volume":"138","author":"JC Alml\u00f6f","year":"2019","unstructured":"Alml\u00f6f JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sj\u00f6wall C, et al. Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing Monogenic systemic lupus erythematosus. Hum Genet. 2019;138(2):141\u201350. https:\/\/doi.org\/10.1007\/s00439-018-01966-7.","journal-title":"Hum Genet"},{"key":"4258_CR6","doi-asserted-by":"publisher","unstructured":"Dasdemir S, Yildiz M, Celebi D, Sahin S, Aliyeva N, Haslak F, et al. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel. Lupus. 2022;31(3):330\u20137. https:\/\/doi.org\/10.1177\/09612033221076733.","DOI":"10.1177\/09612033221076733"},{"issue":"9","key":"4258_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-023-00732-x","volume":"19","author":"CG Vinuesa","year":"2023","unstructured":"Vinuesa CG, Shen N, Ware T. Genetics of SLE: mechanistic insights from Monogenic disease and disease-associated variants. Nat Rev Nephrol. 2023;19(9):558\u201372. https:\/\/doi.org\/10.1038\/s41581-023-00732-x.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4258_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/bor.0000000000001008","volume":"36","author":"Y Qin","year":"2024","unstructured":"Qin Y, Ma J, Vinuesa CG. Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Curr Opin Rheumatol. 2024;36(3):191\u2013200. https:\/\/doi.org\/10.1097\/bor.0000000000001008.","journal-title":"Curr Opin Rheumatol"},{"key":"4258_CR9","doi-asserted-by":"publisher","unstructured":"Torrents D, Mykk\u00e4nen J, Pineda M, Feliubadal\u00f3 L, Est\u00e9vez R, de Cid R, et al. Identification of SLC7A7, encoding y\u2009+\u2009LAT-1, as the lysinuric protein intolerance gene. Nat Genet. 1999;21(3):293\u20136. https:\/\/doi.org\/10.1038\/6809.","DOI":"10.1038\/6809"},{"issue":"4","key":"4258_CR10","doi-asserted-by":"publisher","first-page":"C1077","DOI":"10.1152\/ajpcell.2001.281.4.C1077","volume":"281","author":"CA Wagner","year":"2001","unstructured":"Wagner CA, Lang F, Br\u00f6er S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol. 2001;281(4):C1077\u201393. https:\/\/doi.org\/10.1152\/ajpcell.2001.281.4.C1077.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4258_CR11","doi-asserted-by":"crossref","unstructured":"Perheentupa J, Visakorpi JK. Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism. Lancet. 1965;2(7417):813\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(65)92446-3.","DOI":"10.1016\/S0140-6736(65)92446-3"},{"issue":"4","key":"4258_CR12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1378\/chest.104.4.1176","volume":"104","author":"K Parto","year":"1993","unstructured":"Parto K, Svedstr\u00f6m E, Majurin ML, H\u00e4rk\u00f6nen R, Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest. 1993;104(4):1176\u201382. https:\/\/doi.org\/10.1378\/chest.104.4.1176.","journal-title":"Chest"},{"key":"4258_CR13","doi-asserted-by":"publisher","first-page":"673957","DOI":"10.3389\/fped.2021.673957","volume":"9","author":"JL Contreras","year":"2021","unstructured":"Contreras JL, Ladino MA, Ar\u00e1nguiz K, Mendez GP, Coban-Akdemir Z, Yuan B, et al. Immune dysregulation mimicking systemic lupus erythematosus in a patient with lysinuric protein intolerance: case report and review of the literature. Front Pediatr. 2021;9:673957. https:\/\/doi.org\/10.3389\/fped.2021.673957.","journal-title":"Front Pediatr"},{"issue":"4","key":"4258_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/0046-8177(94)90150-3","volume":"25","author":"K Parto","year":"1994","unstructured":"Parto K, Kallajoki M, Aho H, Simell O. Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients. Hum Pathol. 1994;25(4):400\u20137. https:\/\/doi.org\/10.1016\/0046-8177(94)90150-3.","journal-title":"Hum Pathol"},{"issue":"11","key":"4258_CR15","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.1002\/ppul.23760","volume":"52","author":"G Zhang","year":"2017","unstructured":"Zhang G, Cao L. New mutations in the SLC7A7 gene of two Chinese sisters with lysinuric protein intolerance. Pediatr Pulmonol. 2017;52(11):E94\u20136. https:\/\/doi.org\/10.1002\/ppul.23760.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"4258_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7499\/j.issn.1008-8830.2019.04.014","volume":"21","author":"D Cui","year":"2019","unstructured":"Cui D, Hu YH, Tang G, Shen D, Chen L, Liao JX, et al. [Clinical features of children with lysinuric protein intolerance and SLC7A7 gene mutation: an analysis of 3 cases]. Zhongguo Dang Dai Er Ke Za Zhi. 2019;21(4):375\u201380. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2019.04.014.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"4258_CR17","doi-asserted-by":"publisher","first-page":"9096999","DOI":"10.1155\/2022\/9096999","volume":"2022","author":"A Liu","year":"2022","unstructured":"Liu A, Zhou L, Zhu H, Li Y, Yang J. Systemic lupus erythematosus and hereditary coproporphyria: two different entities diagnosed by WES in the same patient. Biomed Res Int. 2022;2022:9096999. https:\/\/doi.org\/10.1155\/2022\/9096999.","journal-title":"Biomed Res Int"},{"issue":"3","key":"4258_CR18","first-page":"1","volume":"30","author":"HM Hao","year":"2023","unstructured":"Hao HM, Yang HH, Shen LH, Wei HY, Chen YX. Clinical and SLC7A7 gene variation analysis in A child with lysinuric protein intolerance. J Rare Uncommon Dis. 2023;30(3):1\u2013212.","journal-title":"J Rare Uncommon Dis"},{"issue":"12","key":"4258_CR19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.7499\/j.issn.1008-8830.2306148","volume":"25","author":"J Quan","year":"2023","unstructured":"Quan J, Liu XF, Hu K, Hou Q. [Enteral nutrition support for lysinuric protein intolerance: a case report and literature review]. Zhongguo Dang Dai Er Ke Za Zhi. 2023;25(12):1270\u20135. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2306148.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"6","key":"4258_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jaci.2023.03.006","volume":"151","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, He L, Yu Z, Quan M, Song H, Li C. Reversal of SLE and hemophagocytic lymphohistiocytosis caused by lysinuric protein intolerance through allogeneic hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2023;151(6):1673\u20134. https:\/\/doi.org\/10.1016\/j.jaci.2023.03.006.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4258_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ped4.12427","volume":"8","author":"Y Pang","year":"2024","unstructured":"Pang Y, Huo F, Liu X, Fan Y, Zhang Z, Wu J, et al. Lysinuric protein intolerance with novel mutations in solute carrier family 7A member 7 in a Chinese family. Pediatr Investig. 2024;8(2):149\u201353. https:\/\/doi.org\/10.1002\/ped4.12427.","journal-title":"Pediatr Investig"},{"issue":"5","key":"4258_CR22","doi-asserted-by":"publisher","first-page":"e27044","DOI":"10.1016\/j.heliyon.2024.e27044","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Huang Z, Yang S, Lu C, Zhang W, et al. A novel variant in a Chinese Boy with lysinuric protein intolerance: A case report and literature review. Heliyon. 2024;10(5):e27044. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27044.","journal-title":"Heliyon"},{"issue":"1","key":"4258_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.55563\/clinexprheumatol\/zte897","volume":"39","author":"G Li","year":"2021","unstructured":"Li G, Liu H, Li Y, Zhang T, Yao W, Guan W, et al. Genetic heterogeneity in Chinese children with systemic lupus erythematosus. Clin Exp Rheumatol. 2021;39(1):214\u201322. https:\/\/doi.org\/10.55563\/clinexprheumatol\/zte897.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4258_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"4258_CR25","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"9","key":"4258_CR26","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, et al. Definition and initial validation of a lupus low disease activity state (LLDAS). Ann Rheum Dis. 2016;75(9):1615\u201321. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207726.","journal-title":"Ann Rheum Dis"},{"key":"4258_CR27","doi-asserted-by":"crossref","unstructured":"Parto K, Penttinen R, Paronen I, Pelliniemi L, Simell O. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis. 1993;16(2):441\u201350. https:\/\/doi.org\/10.1007\/bf00710296.","DOI":"10.1007\/BF00710296"},{"issue":"1","key":"4258_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/bf00191519","volume":"22","author":"E Svedstr\u00f6m","year":"1993","unstructured":"Svedstr\u00f6m E, Parto K, Marttinen M, Virtama P, Simell O. Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients. Skeletal Radiol. 1993;22(1):11\u20136. https:\/\/doi.org\/10.1007\/bf00191519.","journal-title":"Skeletal Radiol"},{"issue":"10","key":"4258_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ped.12946","volume":"58","author":"A Noguchi","year":"2016","unstructured":"Noguchi A, Nakamura K, Murayama K, Yamamoto S, Komatsu H, Kizu R, et al. Clinical and genetic features of lysinuric protein intolerance in Japan. Pediatr Int. 2016;58(10):979\u201383. https:\/\/doi.org\/10.1111\/ped.12946.","journal-title":"Pediatr Int"},{"issue":"1","key":"4258_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13023-016-0550-8","volume":"12","author":"W Mauhin","year":"2017","unstructured":"Mauhin W, Habarou F, Gobin S, Servais A, Brassier A, Grisel C, et al. Update on lysinuric protein Intolerance, a Multi-faceted disease retrospective cohort analysis from birth to adulthood. Orphanet J Rare Dis. 2017;12(1):3. https:\/\/doi.org\/10.1186\/s13023-016-0550-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4258_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s0022-3476(95)70552-x","volume":"126","author":"G Parenti","year":"1995","unstructured":"Parenti G, Sebastio G, Strisciuglio P, Incerti B, Pecoraro C, Terracciano L, et al. Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course. J Pediatr. 1995;126(2):246\u201351. https:\/\/doi.org\/10.1016\/s0022-3476(95)70552-x.","journal-title":"J Pediatr"},{"key":"4258_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/8904_2015_465","volume":"25","author":"M K\u00e4rki","year":"2016","unstructured":"K\u00e4rki M, N\u00e4nt\u00f6-Salonen K, Niinikoski H, Tanner LM. Urine Beta2-Microglobulin is an early marker of renal involvement in LPI. JIMD Rep. 2016;25:47\u201355. https:\/\/doi.org\/10.1007\/8904_2015_465.","journal-title":"JIMD Rep"},{"issue":"3","key":"4258_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/6815","volume":"21","author":"G Borsani","year":"1999","unstructured":"Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, et al. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet. 1999;21(3):297\u2013301. https:\/\/doi.org\/10.1038\/6815.","journal-title":"Nat Genet"},{"key":"4258_CR34","doi-asserted-by":"crossref","unstructured":"Torrents D, Est\u00e9vez R, Pineda M, Fern\u00e1ndez E, Lloberas J, Shi YB, et al. Identification and characterization of a membrane protein (y\u2009+\u2009L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y\u2009+\u2009L. A candidate gene for lysinuric protein intolerance. J Biol Chem. 1998;273(49):32437\u201345. https:\/\/doi.org\/10.1074\/jbc.273.49.32437.","DOI":"10.1074\/jbc.273.49.32437"},{"key":"4258_CR35","doi-asserted-by":"publisher","unstructured":"Koizumi A, Shoji Y, Nozaki J, Noguchi A, E X, Dakeishi M, et al. A cluster of lysinuric protein intolerance (LPI) patients in a Northern part of Iwate, Japan due to a founder effect. Mass Screen Group Hum Mutat. 2000;16(3):270\u20131. https:\/\/doi.org\/10.1002\/1098-1004(200009)16:3%253C270::Aid-humu14%253E3.0.Co;2-j.","DOI":"10.1002\/1098-1004(200009)16:3%253C270::Aid-humu14%253E3.0.Co;2-j"},{"issue":"1","key":"4258_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/302700","volume":"66","author":"MP Sperandeo","year":"2000","unstructured":"Sperandeo MP, Bassi MT, Riboni M, Parenti G, Buoninconti A, Manzoni M, et al. Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet. 2000;66(1):92\u20139. https:\/\/doi.org\/10.1086\/302700.","journal-title":"Am J Hum Genet"},{"key":"4258_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-5-32","volume":"5","author":"A Barilli","year":"2010","unstructured":"Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Kadija Z, et al. In lysinuric protein intolerance system y\u2009+\u2009L activity is defective in monocytes and in GM-CSF-differentiated macrophages. Orphanet J Rare Dis. 2010;5:32. https:\/\/doi.org\/10.1186\/1750-1172-5-32.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4258_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1189\/jlb.0910510","volume":"90","author":"A Barilli","year":"2011","unstructured":"Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Dall\u2019Asta V. Arginine transport in human monocytic leukemia THP-1 cells during macrophage differentiation. J Leukoc Biol. 2011;90(2):293\u2013303. https:\/\/doi.org\/10.1189\/jlb.0910510.","journal-title":"J Leukoc Biol"},{"key":"4258_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2018.00508","volume":"9","author":"BM Rotoli","year":"2018","unstructured":"Rotoli BM, Barilli A, Visigalli R, Ingoglia F, Milioli M, Di Lascia M, et al. Downregulation of SLC7A7 triggers an inflammatory phenotype in human macrophages and airway epithelial cells. Front Immunol. 2018;9:508. https:\/\/doi.org\/10.3389\/fimmu.2018.00508.","journal-title":"Front Immunol"},{"issue":"8","key":"4258_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/pl00008455","volume":"160","author":"M Aoki","year":"2001","unstructured":"Aoki M, Fukao T, Fujita Y, Watanabe M, Teramoto T, Kato Y, et al. Lysinuric protein intolerance in siblings: complication of systemic lupus erythematosus in the elder sister. Eur J Pediatr. 2001;160(8):522\u20133. https:\/\/doi.org\/10.1007\/pl00008455.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"4258_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/bf01799838","volume":"19","author":"H Parsons","year":"1996","unstructured":"Parsons H, Snyder F, Bowen T, Klassen J, Pinto A. Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance. J Inherit Metab Dis. 1996;19(5):627\u201334. https:\/\/doi.org\/10.1007\/bf01799838.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"4258_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1023\/a:1005440802688","volume":"21","author":"M Di Rocco","year":"1998","unstructured":"Di Rocco M, Buoncompagni A, Gattorno M, Picco P, Vignola S, Borrone C. Complications of lysinuric protein intolerance must be treated with immunosuppressive drugs. J Inherit Metab Dis. 1998;21(6):675\u20136. https:\/\/doi.org\/10.1023\/a:1005440802688.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04258-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04258-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:52:06Z","timestamp":1781639526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04258-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04258-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Children\u2019s Hospital of Fudan University (Approval Number: [2023]192).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}